Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma
Melanomas originating from mucosal surfaces have low mutation burden, genomic instability, and poor prognosis. To identify potential driver genes, we sequenced hundreds of cancer-related genes in 43 human mucosal melanomas, cataloging point mutations, amplifications, and deletions. The gene, which e...
Saved in:
Published in: | Science (American Association for the Advancement of Science) 2018-11, Vol.362 (6418), p.1055-1060 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Melanomas originating from mucosal surfaces have low mutation burden, genomic instability, and poor prognosis. To identify potential driver genes, we sequenced hundreds of cancer-related genes in 43 human mucosal melanomas, cataloging point mutations, amplifications, and deletions. The
gene, which encodes a negative regulator of mitogen-activated protein kinase (MAPK) signaling, was inactivated in 37% of the tumors. Four distinct genotypes were associated with
loss. Using a rapid, tissue-specific CRISPR technique to model these genotypes in zebrafish, we found that
functions as a tumor suppressor, particularly in the context of
mutations.
knockdown caused MAPK activation, increased cell proliferation, and conferred resistance to drugs inhibiting KIT tyrosine kinase activity. These findings provide a rationale for MAPK inhibition in SPRED1-deficient melanomas and introduce a zebrafish modeling approach that can be used more generally to dissect genetic interactions in cancer. |
---|---|
ISSN: | 0036-8075 1095-9203 |